Related references
Note: Only part of the references are listed.Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility
Sih Min Tan et al.
DIABETES (2020)
Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease
Si-Jie Chen et al.
CELL PROLIFERATION (2020)
Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
Manga Motrapu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells
I-Jung Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
Sibei Tao et al.
ACTA DIABETOLOGICA (2019)
Glomerular podocytes in diabetic renal disease
Pawel Podgorski et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy
Wai Han Yiu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases
Zhaoqi Yan et al.
CLINICAL IMMUNOLOGY (2018)
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice
Eleni Beli et al.
DIABETES (2018)
Adipocytokine Involvement in Innate Immune Mechanisms
Paulina Zelechowska et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
Glomerular Endothelial Cells Stress and Cross-Talk with Podocytes in the Development of Diabetic Kidney Disease
Ilse Sofia Daehn
FRONTIERS IN MEDICINE (2018)
Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects
Alireza Soleimani et al.
KIDNEY INTERNATIONAL (2017)
STAT3 signaling in immunity
Emily J. Hillmer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
A novel complement-metabolism-inflammasome axis as a key regulator of immune cell effector function
Giuseppina Arbore et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals
Sabri Ahmed Rial et al.
NUTRIENTS (2016)
Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling
Maayan Levy et al.
CELL (2015)
Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion
Vinicius Andrade-Oliveira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease
Ling Li et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Early chronic kidney disease: diagnosis, management and models of care
Olivier J. Wouters et al.
NATURE REVIEWS NEPHROLOGY (2015)
Microbiota and diabetes: an evolving relationship
Herbert Tilg et al.
GUT (2014)
Role of Innate Immunity in the Pathogenesis of Type 1 and Type 2 Diabetes
Myung-Shik Lee
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
The Gut Microbiome, Kidney Disease, and Targeted Interventions
Ali Ramezani et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?
Marcel H. A. Muskiet et al.
NATURE REVIEWS NEPHROLOGY (2014)
C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-beta/smad3 and IKB alpha Pathway
Ling Li et al.
PLOS ONE (2014)
Intestinal microbiota in metabolic diseases From bacterial community structure and functions to species of pathophysiological relevance
Thomas Clavel et al.
GUT MICROBES (2014)
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Novel roles of complement in renal diseases and their therapeutic consequences
Takehiko Wada et al.
KIDNEY INTERNATIONAL (2013)
Chronic kidney disease alters intestinal microbial flora
Nosratola D. Vaziri et al.
KIDNEY INTERNATIONAL (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
The role of the glomerular endothelium in albumin handling
Simon Satchell
NATURE REVIEWS NEPHROLOGY (2013)
The Renal Endothelium in Diabetic Nephropathy
Theodoros Eleftheriadis et al.
RENAL FAILURE (2013)
Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: A meta-analysis of 39 studies involving more than 20,000 participants
Feng Wang et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway
Qi Cao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses
Lara M. Kingeter et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
VEGF and angiopoietins in diabetic glomerulopathy: How far for a new treatment?
Alessandra Dei Cas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Interactions Between the Microbiota and the Immune System
Lora V. Hooper et al.
SCIENCE (2012)
Pathobionts of the gastrointestinal microbiota and inflammatory disease
Janet Chow et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Transcriptome Analysis of Human Diabetic Kidney Disease
Karolina I. Woroniecka et al.
DIABETES (2011)
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
Ian H. de Boer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue
Lucie Geurts et al.
FRONTIERS IN MICROBIOLOGY (2011)
Gut Microbiota in Health and Disease
Inna Sekirov et al.
PHYSIOLOGICAL REVIEWS (2010)
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Ting-Chi Lu et al.
KIDNEY INTERNATIONAL (2009)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum
Martin Baumgart et al.
ISME JOURNAL (2007)
Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats
H Zhou et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli
AK Banes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: Glycoxidation-mediated local complement activation
N Uesugi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
TV Arumugam et al.
KIDNEY INTERNATIONAL (2003)
Identification of a potent and orally active non-peptide C5a receptor antagonist
H Sumichika et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats
M Kakimoto et al.
DIABETES (2002)
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
F Amiri et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
